Lance A. Liotta

Center for Applied Proteomics and Molecular Medicine, George Mason University

Research Area

Biography

Lance A. Liotta has not added Biography.
If you are Lance A. Liotta and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 11	2014
Publication title	2014

Other Publications

Article	Year
Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urologic oncology\| PubMed ID: 15283891	2004
Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert review of molecular diagnostics\| PubMed ID: 12138495	2002
Stromal therapy: the next step in ovarian cancer treatment. Journal of the National Cancer Institute\| PubMed ID: 12165628	2002
Clinical proteomics: translating benchside promise into bedside reality. Nature reviews. Drug discovery\| PubMed ID: 12209149	2002
Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute\| PubMed ID: 12381711	2002
Genomics and proteomics: application of novel technology to early detection and prevention of cancer. Cancer detection and prevention\| PubMed ID: 12430629	2002
Frozen protein arrays: a new method for arraying and detecting recombinant and native tissue proteins. Proteomics\| PubMed ID: 12442248	2002
Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications. American journal of clinical pathology\| PubMed ID: 12472280	2002
Cancer's deadly signature. Nature genetics\| PubMed ID: 12509774	2003
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12538450	2003
Proteomic technologies to study diseases of the lymphatic vascular system. Annals of the New York Academy of Sciences\| PubMed ID: 12543730	2002
Proteomic analysis at the bedside: early detection of cancer. Trends in biotechnology\| PubMed ID: 12570157	2002
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecologic oncology\| PubMed ID: 12586081	2003
Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Technology in cancer research & treatment\| PubMed ID: 12625785	2002
Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clinical chemistry\| PubMed ID: 12651801	2003
Proteomic applications for the early detection of cancer. Nature reviews. Cancer\| PubMed ID: 12671665	2003
Protein microarrays: meeting analytical challenges for clinical applications. Cancer cell\| PubMed ID: 12726858	2003
Cancer: Out of air is not out of action. Nature\| PubMed ID: 12789320	2003
Clinical applications of proteomics. The Journal of nutrition\| PubMed ID: 12840227	2003
Fibronectin-based masking molecule blocks platelet adhesion. Bioconjugate chemistry\| PubMed ID: 12862420	2003
Counterpoint: The vision for a new diagnostic paradigm. Clinical chemistry\| PubMed ID: 12881442	2003
Clinical applications of proteomics: proteomic pattern diagnostics. Journal of mammary gland biology and neoplasia\| PubMed ID: 12882527	2002
Dilution of protein gel stain results in retention of staining capacity. BioTechniques\| PubMed ID: 12951779	2003
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics\| PubMed ID: 12973739	2003
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer research\| PubMed ID: 14500354	2003
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer research\| PubMed ID: 14500380	2003
Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14500904	2003
Clinical proteomics: written in blood. Nature\| PubMed ID: 14586448	2003
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics\| PubMed ID: 14595806	2003
Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics\| PubMed ID: 14595807	2003
Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics\| PubMed ID: 14595813	2003
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14623978	2003
Molecular diagnostics. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program\| PubMed ID: 14633786	2003
Clinical proteomics: application at the bedside. Contributions to nephrology\| PubMed ID: 14650227	2004
Drosophila invasive tumors: a model for understanding metastasis. Cell cycle (Georgetown, Tex.)\| PubMed ID: 14657663	2004
Use of proteomic analysis to monitor responses to biological therapies. Expert opinion on biological therapy\| PubMed ID: 14680471	2004
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer cell\| PubMed ID: 14706336	2003
Serum proteomics in cancer diagnosis and management. Annual review of medicine\| PubMed ID: 14746511	2004
Biomarker amplification by serum carrier protein binding. Disease markers\| PubMed ID: 14757941	2003-2004
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 14767488	2004
Blasting into the microworld of tissue proteomics: a new window on cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14871957	2004
Use of proteomic patterns to screen for gastrointestinal malignancies. Surgery\| PubMed ID: 14976472	2004
Trapping radioactive carbon dioxide during cellular metabolic assays under standard culture conditions: description of a unique gas-capturing device. Journal of biochemical and biophysical methods\| PubMed ID: 14980785	2004
Proteomic analysis of lymph. Proteomics\| PubMed ID: 14997497	2004
Ovarian cancer detection by logical analysis of proteomic data. Proteomics\| PubMed ID: 14997498	2004
Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP). Proteomics\| PubMed ID: 14997501	2004
STUDENTJAMA. Molecular technologies for personalized cancer management. JAMA : the journal of the American Medical Association\| PubMed ID: 15069056	2004
Proteomic approaches in cancer risk and response assessment. Trends in molecular medicine\| PubMed ID: 15102358	2004
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Current opinion in biotechnology\| PubMed ID: 15102462	2004
Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. Journal of proteome research\| PubMed ID: 15113096	2004
An investigation into the human serum "interactome". Electrophoresis\| PubMed ID: 15174051	2004
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection. Toxicologic pathology\| PubMed ID: 15209412	2004
Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays. Briefings in functional genomics & proteomics\| PubMed ID: 15239896	2002
Clinical proteomics and biomarker discovery. Annals of the New York Academy of Sciences\| PubMed ID: 15251975	2004
Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients. Disease markers\| PubMed ID: 15258334	2003-2004
Protein microarray detection strategies: focus on direct detection technologies. Journal of immunological methods\| PubMed ID: 15261576	2004
Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics. Proteomics\| PubMed ID: 15274129	2004
Anoikis: cancer and the homeless cell. Nature\| PubMed ID: 15329701	2004
Tumor invasion and metastasis: getting more basic to come closer to the patient. An interview with Lance A. Liotta. The International journal of developmental biology\| PubMed ID: 15349830	2004
Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics\| PubMed ID: 15352252	2004
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. The Journal of urology\| PubMed ID: 15371828	2004
A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer research\| PubMed ID: 15375002	2004
Opportunities for nanotechnology-based innovation in tissue proteomics. Biomedical microdevices\| PubMed ID: 15377833	2004
Expression microdissection: operator-independent retrieval of cells for molecular profiling. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 15538110	2004
Biomarkers of ovarian tumours. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 15541961	2004
Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clinical breast cancer\| PubMed ID: 15585078	2004
Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Human genomics\| PubMed ID: 15601541	2004
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Molecular & cellular proteomics : MCP\| PubMed ID: 15671044	2005
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15671551	2005
Importance of communication between producers and consumers of publicly available experimental data. Journal of the National Cancer Institute\| PubMed ID: 15713967	2005
L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin. Lipids in health and disease\| PubMed ID: 15737239	2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. Arthritis and rheumatism\| PubMed ID: 15751091	2005
Pathology of the future: molecular profiling for targeted therapy. Cancer investigation\| PubMed ID: 15779867	2005
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer research\| PubMed ID: 15867384	2005
Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda, Md.)\| PubMed ID: 15888576	2005
Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjugate chemistry\| PubMed ID: 15898722	2005
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15908672	2005
CSF proteome: a protein repository for potential biomarker identification. Expert review of proteomics\| PubMed ID: 15966853	2005
Reverse-phase protein microarrays for tissue-based analysis. Current opinion in molecular therapeutics\| PubMed ID: 15977421	2005
Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling. Cancer\| PubMed ID: 16015639	2005
A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. Cancer research\| PubMed ID: 16061631	2005
Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clinical chemistry\| PubMed ID: 16099937	2005
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16115925	2005
Cancer proteomics: many technologies, one goal. Expert review of proteomics\| PubMed ID: 16209649	2005
Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Bioscience reports\| PubMed ID: 16222423	2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research. Clinical advances in hematology & oncology : H&O\| PubMed ID: 16224427	2003
The promise of proteomics. Clinical advances in hematology & oncology : H&O\| PubMed ID: 16258432	2003
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. The Journal of clinical investigation\| PubMed ID: 16395400	2006
Nanoparticles: potential biomarker harvesters. Current opinion in chemical biology\| PubMed ID: 16413816	2006
A control theoretic paradigm for cell signaling networks: a simple complexity for a sensitive robustness. Current opinion in chemical biology\| PubMed ID: 16414304	2006
The amplified peptidome: the new treasure chest of candidate biomarkers. Current opinion in chemical biology\| PubMed ID: 16418009	2006
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16467090	2006
Identification and characterization of endogenous Langerin ligands in murine extracellular matrix. The Journal of investigative dermatology\| PubMed ID: 16557233	2006
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer biology & therapy\| PubMed ID: 16627987	2006
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics\| PubMed ID: 16645983	2006
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. Journal of proteome research\| PubMed ID: 16674117	2006
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays. Nature clinical practice. Oncology\| PubMed ID: 16683004	2006
Laser capture microdissection. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 16719357	2006
Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. The Journal of biological chemistry\| PubMed ID: 16926147	2006
Breast cancer growth prevention by statins. Cancer research\| PubMed ID: 16951186	2006
Physicochemically modified silicon as a substrate for protein microarrays. Biomaterials\| PubMed ID: 16987550	2007
The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nature reviews. Cancer\| PubMed ID: 17093504	2006
Glia maturation factor gamma (GMFG): a cytokine-responsive protein during hematopoietic lineage development and its functional genomics analysis. Genomics, proteomics & bioinformatics\| PubMed ID: 17127212	2006
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Molecular cancer research : MCR\| PubMed ID: 17314270	2007
Tumor vascular proteins as biomarkers in ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17327606	2007
Laser-capture microdissection. Nature protocols\| PubMed ID: 17406286	2006
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer research\| PubMed ID: 17409454	2007
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clinical chemistry\| PubMed ID: 17463175	2007
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer\| PubMed ID: 17487852	2007
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Annals of surgical oncology\| PubMed ID: 17594124	2007
A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology (Baltimore, Md.)\| PubMed ID: 17596878	2007
Nanotechnology in clinical proteomics. Nanomedicine (London, England)\| PubMed ID: 17716185	2007
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy. Cancer genomics & proteomics\| PubMed ID: 17878519	2007
Multidimensional metamorphosis of biomarker science. Expert review of molecular diagnostics\| PubMed ID: 17892352	2007
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. Expert review of molecular diagnostics\| PubMed ID: 17892368	2007
Laser capture microdissection technology. Expert review of molecular diagnostics\| PubMed ID: 17892370	2007
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17911267	2007
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nature reviews. Drug discovery\| PubMed ID: 17932492	2007
Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano letters\| PubMed ID: 18076201	2008
Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. Clinical chemistry\| PubMed ID: 18160722	2008
Reverse phase protein microarrays for monitoring biological responses. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18217695	2007
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. Journal of proteome research\| PubMed ID: 18257519	2008
Automated laser capture microdissection for tissue proteomics. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18370312	2008
Reverse phase protein microarrays for theranostics and patient-tailored therapy. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18370315	2008
Molecular network analysis using reverse phase protein microarrays for patient tailored therapy. Advances in experimental medicine and biology\| PubMed ID: 18593023	2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. Clinical chemistry\| PubMed ID: 18606634	2008
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Molecular & cellular proteomics : MCP\| PubMed ID: 18667411	2008
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with... Molecular & cellular proteomics : MCP\| PubMed ID: 18687633	2008
Application of physicochemically modified silicon substrates as reverse-phase protein microarrays. Journal of proteome research\| PubMed ID: 19170514	2009
Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PloS one\| PubMed ID: 19274087	2009
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. Journal of proteome research\| PubMed ID: 19275204	2009
Reverse-phase protein microarrays for theranostics and patient tailored therapy. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 19381949	2009
Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clinics in laboratory medicine\| PubMed ID: 19389547	2009
Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer. The Journal of pathology\| PubMed ID: 19396842	2009
Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response. Archives of ophthalmology\| PubMed ID: 19433709	2009
An initial characterization of the serum phosphoproteome. Journal of proteome research\| PubMed ID: 19824718	2009
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer. Neoplasia (New York, N.Y.)\| PubMed ID: 19881954	2009
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients. PloS one\| PubMed ID: 19888321	2009
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. Journal of Alzheimer's disease : JAD\| PubMed ID: 20157261	2010
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 20195244	2010
Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. Drug testing and analysis\| PubMed ID: 20355230	2009
Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PloS one\| PubMed ID: 20421921	2010
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells. Journal of proteome research\| PubMed ID: 20433201	2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. Journal of proteome research\| PubMed ID: 20455595	2011
Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles. Nano research\| PubMed ID: 20467576	2008
Monitoring proteins and protein networks using reverse phase protein arrays. Disease markers\| PubMed ID: 20534907	2010
Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery. Journal of materials chemistry\| PubMed ID: 20585471	2009
Mass spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit. Clinical chemistry\| PubMed ID: 20660141	2010
Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Critical reviews in clinical laboratory sciences\| PubMed ID: 20858067	2010
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics. Clinical applications\| PubMed ID: 20871745	2009
Synthesis and characterization of hydrogel particles containing Cibacron Blue F3G-A. Colloids and surfaces. A, Physicochemical and engineering aspects\| PubMed ID: 20871782	2010
Reverse phase protein microarrays advance to use in clinical trials. Molecular oncology\| PubMed ID: 20974554	2010
The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. Biomaterials\| PubMed ID: 21035184	2011
Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia. International journal of oncology\| PubMed ID: 21132263	2011
A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood. Proteomics. Clinical applications\| PubMed ID: 21136667	2007
Mass spectrometry-based characterization of the vitreous phosphoproteome. Proteomics. Clinical applications\| PubMed ID: 21137027	2010
What is the malignant nature of human ductal carcinoma in situ? Nature reviews. Cancer\| PubMed ID: 21150936	2011
A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. Experimental dermatology\| PubMed ID: 21158936	2011
Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Molecular & cellular proteomics : MCP\| PubMed ID: 21189417	2011
Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 21242333	2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. The American journal of pathology\| PubMed ID: 21281788	2011
Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations. Journal of proteome research\| PubMed ID: 21309613	2011
Reverse phase protein microarrays: fluorometric and colorimetric detection. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21370072	2011
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation. Journal of proteome research\| PubMed ID: 21574647	2011
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways. Breast cancer research and treatment\| PubMed ID: 21647677	2011
One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens. PloS one\| PubMed ID: 21858221	2011
Reverse phase protein microarrays for clinical applications. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21901589	2011
Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21901591	2011
Cancer biomarkers: closer to delivering on their promise. Cancer cell\| PubMed ID: 21907916	2011
Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers. Journal of the American Chemical Society\| PubMed ID: 21999289	2011
Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. Journal of proteome research\| PubMed ID: 22050456	2012
Laser capture microdissection: Arcturus(XT) infrared capture and UV cutting methods. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22081345	2012
Inventions and patents: a practical tutorial. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22081360	2012
Regulatory approval pathways for molecular diagnostic technology. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22081361	2012
Small business development for molecular diagnostics. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22081362	2012
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins. Journal of proteome research\| PubMed ID: 22256890	2012
The spectra count label-free quantitation in cancer proteomics. Cancer genomics & proteomics\| PubMed ID: 22593248	2012
MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells. Electrophoresis\| PubMed ID: 22740473	2012
-Omics and cancer biomarkers: link to the biological truth or bear the consequences. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 22810955	2012
Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples. BioTechniques\| PubMed ID: 22946677	2012
Laser capture microdissection for protein and NanoString RNA analysis. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 23027006	2013
Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23045247	2012
Role of km23-1 in RhoA/actin-based cell migration. Biochemical and biophysical research communications\| PubMed ID: 23079622	2012
Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry. Cancer genomics & proteomics\| PubMed ID: 23162076	2012
Attacking breast cancer at the preinvasion stage by targeting autophagy. Women's health (London, England)\| PubMed ID: 23477322	2013
Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23493346	2013
Quantum dots for biomedical applications. Expert opinion on medical diagnostics\| PubMed ID: 23495661	2008
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells. Analytical and bioanalytical chemistry\| PubMed ID: 23508580	2013
Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures. Molecular cancer research : MCR\| PubMed ID: 23635402	2013
Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. Experimental cell research\| PubMed ID: 23669273	2013
Dynamic protein pathway activation mapping of adipose-derived stem cell differentiation implicates novel regulators of adipocyte differentiation. Molecular & cellular proteomics : MCP\| PubMed ID: 23750025	2013
Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways. Clinical & experimental metastasis\| PubMed ID: 23877430	2014
Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. Journal of sports medicine & doping studies\| PubMed ID: 24014257	2012
Cancer metabolism and mass spectrometry-based proteomics. Cancer letters\| PubMed ID: 24262660	2013
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling. BMC research notes\| PubMed ID: 24304724	2013
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer research\| PubMed ID: 24346432	2013
Integrated genomic and epigenomic analysis of breast cancer brain metastasis. PloS one\| PubMed ID: 24489661	2014
Multiplex Proteomic Analysis of Cells in Fine Needle Aspiration Specimens: How Soon Can We Expect to Individualize Therapy by Comparing Pre- and Posttreatment Biopsies? Clinical chemistry\| PubMed ID: 24718910	2014
Protein pathway analysis in Clinical Proteomics using protein microarrays. Drug discovery today. Technologies\| PubMed ID: 24982012	2005
Protein painting reveals solvent-excluded drug targets hidden within native protein-protein interfaces. Nature communications\| PubMed ID: 25048602	2014